Longevity Part 5: Advanced Attia-Level Targets & Geroscience

Once you have mastered the foundational pillars: Zone 2 aerobic endurance, heavy progressive resistance training, 7 to 8.5 hours of sleep, and adequate whole-food protein, you are ready to transition into advanced Medicine 3.0.

In traditional medicine, a lab result is marked "normal" if you fall within 95% of a diseased, sedentary population.

In clinical longevity medicine and geroscience, as exemplified by Dr. Peter Attia in Outlive, we do not compare ourselves to the average population; we optimize biomarkers to physiological targets that actively halt disease progression.

What are the strict clinical biomarker targets of Medicine 3.0, how does Lifetime Cumulative ApoB exposure dictate heart disease, how can inexpensive generic medications achieve aggressive cardiovascular protection, and what is the emerging role of geroscience therapeutics like Rapamycin?

1. Traditional Reference Ranges vs. Optimal Longevity Targets#

Standard clinical laboratory reference ranges represent a statistical bell curve of the general population: a population in which over 70% of adults are overweight or obese and 50% have pre-diabetes or diabetes:

[THE DIVERGENCE: POPULATION AVERAGE VS. LONGEVITY TARGET]

Biomarker           Standard Lab "Normal"        Medicine 3.0 Longevity Target
─────────           ─────────────────────        ─────────────────────────────
Apolipoprotein B    < 90 to 100 mg/dL            < 60 mg/dL (Primary) / < 40–50 mg/dL (Regression)
Fasting Insulin     2.6 to 24.9 µIU/mL           < 5.0 µIU/mL (HOMA-IR < 1.0)
Fasting Glucose     70 to 99 mg/dL               75 to 88 mg/dL
Hemoglobin A1c      < 5.7% (Normal)              < 5.2% to 5.4%
hs-CRP              < 3.0 mg/L                   < 0.5 mg/L
Triglycerides       < 150 mg/dL                  < 75 to 90 mg/dL (TG/HDL Ratio < 1.5)
ALT (Liver Enzyme)  < 45 to 55 U/L               < 20 to 25 U/L (Early Fatty Liver Warning)

• The Clinical Takeaway: A fasting insulin of 18 µIU/mL will be flagged as normal by a standard lab, despite representing severe underlying metabolic insulin resistance that accelerates vascular damage.

2. The Lifetime Cumulative Exposure Model (ApoB AUC)#

The foundational principle of cardiovascular longevity, established by Dr. Brian Ference of the University of Cambridge (JACC 2018), is that atherosclerotic plaque is a product of particle concentration multiplied by time:

Lifetime ASCVD Risk = Mean Serum ApoB Concentration × Years of Exposure (Age)

[THE CUMULATIVE ATHEROGENIC EXPOSURE THRESHOLD]

Cumulative
ApoB Burden
 (mg-years)
   8000 ──                                            ▲ (CLINICAL PLAQUE RUPTURE / INFARCT)
   6000 ──                                           ╱
   4000 ──                  ────────────────────────╱   (High ApoB AUC: Infarct at Age 45)
   2000 ──                 ╱
      0 ──────────────────╱─────────────────────────────────────────────────────────────
          Age 20        Age 30        Age 40        Age 50        Age 60        Age 70
                                                       (Low ApoB AUC: Plaque Free at 80)

• The Mendelian Proof: Individuals with genetic variants that lower ApoB by just 38.7 mg/dL from birth experience a 54% reduction in lifetime coronary heart disease.
• The Longevity Strategy: Lowering ApoB early in life, during your 30s, 40s, and 50s, flattens the curve, ensuring you never cross the cumulative atherogenic threshold in your lifetime.

3. Accessible Generic Pharmacotherapy for Prevention#

Achieving an ApoB < 60 mg/dL or reversing early metabolic resistance does not require expensive designer drugs. Modern cardiology utilizes inexpensive generic medications:

[LOW-COST GENERIC CARDIOVASCULAR PREVENTION]
                             │
    ┌────────────────────────┴────────────────────────┐
    ▼                                                 ▼
[GENERIC EZETIMIBE (10 mg daily)]         [LOW-DOSE STATIN (Rosuvastatin 5 mg)]
  - ~$5 to $10 / month.                     - ~$5 to $10 / month.
  - Inhibits NPC1L1 cholesterol absorption. - Upregulates hepatic LDL receptors.
  - LOWERS ApoB BY 15% TO 20%.              - LOWERS ApoB BY 35% TO 45%.
  - ZERO muscle side effects.               - POTENT ANTI-INFLAMMATORY (LOWERS hs-CRP).

The Low-Dose Combination Strategy#

• Why Combination Beats High-Dose Monotherapy: Combining a micro-dose statin (such as Rosuvastatin 5 mg daily or every other day) with Ezetimibe 10 mg daily achieves a greater than 50% drop in ApoB while virtually eliminating the risk of statin-associated muscle aches (myalgias) or elevated blood glucose.
• Combined Cost: Approximately $10 to $15 per month via standard generic prescription discount programs (such as Mark Cuban Cost Plus Drugs or GoodRx).

4. Cellular Autophagy & The Geroscience Frontier#

Beyond cardiovascular and metabolic prevention, geroscience targets the fundamental cellular hallmarks of aging:

[NUTRIENT ABUNDANCE (mTORC1 Activated)]
  - Drives cell growth, protein synthesis (p70S6K1), and muscle building.
  - BLOCKS MACROAUTOPHAGY & LYSOSOMAL CELLULAR RECYCLING.
                            │
                            ▼ (Intermittent Caloric Restriction / Exercise / Pulsed Rapamycin)
                            │
[NUTRIENT DEPRIVATION / mTORC1 INHIBITION]
  - Releases the brake on the ULK1 autophagy complex.
  - Cells engulf and break down damaged organelles (MITOPHAGY) and toxic protein aggregates.

The Emerging Science of Rapamycin (Sirolimus)#

• The NIA Interventions Testing Program (ITP): Rapamycin is the single most reproducible pharmacological molecule extending median and maximum mammalian lifespan (by 15% to 26%).
• The Weekly Longevity Protocol: In longevity research, clinicians study intermittent weekly pulsing (5 to 6 mg once weekly) to trigger a 24-to-48-hour wave of cellular autophagy while avoiding the continuous mTORC2 disruption that causes immunosuppression.

5. Early Cancer Detection & Advanced Diagnostic Imaging#

To complete the Medicine 3.0 shield, incorporate targeted, high-yield cancer and vascular screenings:

ADVANCED EARLY SCREENING PROTOCOLS:
1. Coronary Computed Tomography Angiography (CCTA with AI / Cleerly):
   - Far superior to basic Calcium Scoring (CAC); visualizes soft, non-calcified lipid plaque before it calcifies.
2. Colorectal Cancer Screening:
   - Colonoscopy starting at age 45 (or age 40 with family history); annual Fecal Immunochemical Tests (FIT).
3. Dermatological Full-Body Skin Exam:
   - Annual total body photography with a dermatologist to catch early melanoma.
4. Low-Dose CT Lung Screening:
   - In individuals with significant past smoking history.

6. The Complete Master Longevity Protocol#

Pulling together all 5 chapters into an accessible, lifelong weekly operating system:

[THE COMPLETE MEDICINE 3.0 WEEKLY OPERATING BLUEPRINT]

• AEROBIC BASE:        150–180 minutes of Zone 2 cardio weekly (brisk incline walking, rucking, cycling).
• PEAK CARDIO (VO2):   1 session weekly of 4x4 high-intensity intervals (4 min hard, 4 min recovery).
• RESISTANCE TRAINING: 2 to 3 days weekly of progressive compound lifting (squat, hinge, push, pull, carry).
• RESTORATIVE SLEEP:   7 to 8.5 hours in a cool (65°F–68°F), pitch-black room; morning outdoor sunlight.
• NUTRITION:           1.6 to 2.2 g/kg protein pacing (30–45g/meal) + 35–45g fiber + zero ultra-processed foods.
• THE $40 STACK:       Creatine (5g), Vitamin D3+K2 (2000–5000 IU), Magnesium (200–400mg), Omega-3 (2g).
• ANNUAL BLOOD PANEL:  ApoB (< 60 mg/dL), Fasting Insulin (< 5.0 µIU/mL / HOMA-IR < 1.0), hs-CRP (< 0.5 mg/L).

The Longevity Series Roadmap#

• Part 1: Longevity Part 1: Healthspan, Morbidity & The Four Horsemen
• Part 2: Longevity Part 2: Zero-Cost Exercise, Zone 2 Cardio & Sleep Architecture
• Part 3: Longevity Part 3: Budget Nutrition, Protein Pacing & The $40 Stack
• Part 4: Longevity Part 4: The Budget Biomarker Panel Under $150
• Part 5: Longevity Part 5: Advanced Attia-Level Targets & Geroscience (You are here)

Scientific References & Primary Literature#

1. Attia P, Gifford B. Outlive: The Science and Art of Longevity. Harmony Books; 2023.
2. Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. J Am Coll Cardiol. 2018;72(10):1141-1156. doi:10.1016/j.jacc.2018.06.046.
3. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-395. doi:10.1038/nature08221.
4. SCOT-HEART Investigators. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med. 2018;379(10):924-933. doi:10.1056/NEJMoa1805971.
5. Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (CANTOS Trial). N Engl J Med. 2017;377(12):1119-1131. doi:10.1056/NEJMoa1707914.

Master Your Longevity Records with Meridian#

Monitoring your laboratory blood biomarkers over time gives you objective validation that your diet, exercise, and lifestyle habits are keeping your metabolic health and glucose tolerance in optimal ranges.

Meridian is an offline personal health vault for iPhone designed to give you complete ownership of your medical diagnostic data.

• Instant Lab Report Extraction: Take a photo or upload a PDF of your Comprehensive Metabolic Panels, Lipid Panels, ApoB, Fasting Insulin, hs-CRP, and DEXA scans from Quest, Labcorp, or your clinic. Meridian extracts all biomarkers on-device using Apple VisionKit.
• Decade-Long Longevity Analysis: Graph your ApoB trajectories, HOMA-IR sensitivity curves, and lipid ratios across your entire adult life with complete privacy.
• 100% On-Device & Private: Protected by hardware AES-256 encryption and FaceID. Zero cloud servers. Zero data tracking.

Take control of your healthspan and medical privacy today. Download Meridian on the App Store and keep your diagnostic records organized, private, and secure.